Main menu
SIGU 2025
23 - 25 September 2025 CEST
Milan, Italy

Oxford Nanopore at SIGU 2025

SIGU intends to collaborate with those in Italy who are interested in research and any type of in-depth study related to the disciplines of Medical Genetics and Human Genetics, in particular by developing quality criteria for Medical Genetics laboratories operating in public and private health facilities, contributing to the development of guidelines in the field of Human Genetics research and promoting by all means public awareness of the functions, the potential and limits of the diagnostic techniques of Human Genetics.

Oxford Nanopore will be exhibiting at the Italian Society of Human Genetics (SIGU) congress in September, 2025. We will also host a Corporate Session on Wednesday, 24 September, 2025.

The latest advances in Oxford Nanopore sequencing are enabling researchers to uncover the full spectrum of genetic and epigenetic variation in rare and complex diseases—supported by flexible, end-to-end workflows and intuitive analysis tools designed to streamline discovery. This workshop will showcase how this approach is helping to reveal methylation signatures, uncover disease mechanisms hidden within structural variants, and has the potential to resolve previously undiagnosed cases—bringing clarity to rare disease, without complexity. Presentations will include: a new cytogenetic analysis framework capable of detecting pathogenic copy number variants in real time; the use of sequencing in uncovering missing heritability through access to “dark” genomic regions and methylation profiling; and multi-disorder validation studies demonstrating utility across a spectrum of variant types. Attendees will hear how sequencing reads of any length are being used to accelerate research in complex disease areas—supporting deeper discovery with greater efficiency.

Details and registration below.

Agenda

Agenda

14:10 – 15:10 hrs CEST

Agenda (subject to change)

14:10 - 14:15 hrs

Introduction

Angelica Vittori, Oxford Nanopore Technologies

14:15 - 14:30 hrs

Clinical validation of Oxford Nanopore long-read WGS across multiple rare disorders and multiple mutation types including episignature

Alessandra Renieri, Full Professor of Medical Genetics, University of Siena

14:30 - 14:45 hrs

Oxford Nanopore LR-WGS to handle missing heritability in rare diseases

Cecilia Mancini, Postdoctoral Researcher, Bambino Gesù Children’s Hospital

14:45 - 15:00 hrs

Third generation cytogenetic analysis

Alberto Magi, Associate Professor of Bioengineering, University of Florence

15:00 - 15:10 hrs

Q&A

Speakers

Clinical validation of Oxford Nanopore long-read WGS across multiple rare disorders and multiple mutation types including episignature

Alessandra Renieri, University of Siena

...

Oxford Nanopore LR-WGS to handle missing heritability in rare diseases

Cecilia Mancini, Bambino Gesù Children’s Hospital

...

picture of Alberto Magi

Third generation cytogenetic analysis

Alberto Magi, University of Florence

...

Register

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag